As most of the cancer cells including lung cancer cells express high levels of EGFR [66], we engineered the HUVEC-EVs via postinsertion of GE11 peptide, which has been reported to interact with the EGFR receptor [45,46,68]. The gene discussed is EGFR; the disease is cancer.